BR0212409A - Composto esteroidal, uso do mesmo, e, método de tratamento de um animal ou de uma pessoa humana necessitando de estimulação androgênica para um efeito androgênico - Google Patents
Composto esteroidal, uso do mesmo, e, método de tratamento de um animal ou de uma pessoa humana necessitando de estimulação androgênica para um efeito androgênicoInfo
- Publication number
- BR0212409A BR0212409A BR0212409-2A BR0212409A BR0212409A BR 0212409 A BR0212409 A BR 0212409A BR 0212409 A BR0212409 A BR 0212409A BR 0212409 A BR0212409 A BR 0212409A
- Authority
- BR
- Brazil
- Prior art keywords
- animal
- treating
- steroid compound
- human person
- androgenic effect
- Prior art date
Links
- 239000003098 androgen Substances 0.000 title abstract 3
- 230000001548 androgenic effect Effects 0.000 title abstract 3
- -1 Steroid compound Chemical class 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000000638 stimulation Effects 0.000 title abstract 2
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 239000001257 hydrogen Substances 0.000 abstract 2
- 238000011282 treatment Methods 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 230000003637 steroidlike Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0062—Estrane derivatives substituted in position 17 alfa not substituted in position 17 beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
"COMPOSTO ESTEROIDAL, USO DO MESMO, E, MéTODO DE TRATAMENTO DE UM ANIMAL OU DE UMA PESSOA HUMANA NECESSITANDO DE ESTIMULAçãO ANDROGêNICA PARA UM EFEITO ANDROGêNICO". Esta invenção refere-se aos compostos esteroidais possuindo a fórmula (I), na qual: R^ 1^ é O, (H,H), (H,OH), NOH, por meio do qual OH é opcionalmente eterificado ou esterificado; R^ 2^ e R^ 3^ são independentemente hidrogênio ou (C1~ 1~-~ 4~) alquila e pelo menos um de R^ 2^ e R^ 3^ é (C~ 1~-~ 4~) alquila; R^ 4^ é hidrogênio ou (C1~ 1~-~ 15~) acila para uso em tratamento relacionados com androgênio, tal como insuficiência de androgênio e contracepção masculina ou feminina.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP01203455 | 2001-09-12 | ||
| PCT/EP2002/010041 WO2003022864A1 (en) | 2001-09-12 | 2002-09-06 | 17alpha-hydroxy-14beta-steroids with hormonal effect |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0212409A true BR0212409A (pt) | 2004-08-03 |
Family
ID=8180920
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0212409-2A BR0212409A (pt) | 2001-09-12 | 2002-09-06 | Composto esteroidal, uso do mesmo, e, método de tratamento de um animal ou de uma pessoa humana necessitando de estimulação androgênica para um efeito androgênico |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US7169769B2 (pt) |
| EP (1) | EP1427748B1 (pt) |
| JP (1) | JP4471653B2 (pt) |
| KR (1) | KR100940054B1 (pt) |
| CN (1) | CN1257913C (pt) |
| AR (1) | AR036462A1 (pt) |
| AT (1) | ATE395352T1 (pt) |
| AU (1) | AU2002339536B2 (pt) |
| BR (1) | BR0212409A (pt) |
| CA (1) | CA2505575C (pt) |
| CY (1) | CY1108152T1 (pt) |
| DE (1) | DE60226623D1 (pt) |
| DK (1) | DK1427748T3 (pt) |
| EC (1) | ECSP045012A (pt) |
| ES (1) | ES2305306T3 (pt) |
| HR (1) | HRP20040193A2 (pt) |
| HU (1) | HUP0402139A3 (pt) |
| IL (2) | IL160451A0 (pt) |
| IS (1) | IS2555B (pt) |
| MX (1) | MXPA04002418A (pt) |
| NO (1) | NO326624B1 (pt) |
| NZ (1) | NZ531487A (pt) |
| PL (1) | PL207493B1 (pt) |
| PT (1) | PT1427748E (pt) |
| RU (1) | RU2294332C2 (pt) |
| TW (1) | TWI221154B (pt) |
| WO (1) | WO2003022864A1 (pt) |
| ZA (1) | ZA200401992B (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI221154B (en) | 2001-09-12 | 2004-09-21 | Akzo Nobel Nv | 17alpha-hydroxy-14beta-steroids with hormonal effect |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3338925A (en) * | 1965-10-25 | 1967-08-29 | Syntex Corp | 17-substituted 14beta-estr-4-enes |
| EP1163259B1 (en) * | 1999-03-08 | 2002-11-20 | Akzo Nobel N.V. | 14.beta.,17-alpha-hydroxymethylandrostane derivatives as androgens |
| AU4299301A (en) * | 2000-02-29 | 2001-09-12 | National University Of Singapore, The | A method for modulating steroidogenic activity |
| US6391868B2 (en) * | 2000-05-10 | 2002-05-21 | Lpt Research, Inc. | Use of 5-alpha-androst-1-en-3,17-dione to increase the level of the anabolic/androgenic hormone 17-beta-hydroxy-5-alpha-androst-1-en-3-one in humans |
| TWI221154B (en) | 2001-09-12 | 2004-09-21 | Akzo Nobel Nv | 17alpha-hydroxy-14beta-steroids with hormonal effect |
-
2002
- 2002-07-19 TW TW091116164A patent/TWI221154B/zh not_active IP Right Cessation
- 2002-09-06 RU RU2004110934/04A patent/RU2294332C2/ru not_active IP Right Cessation
- 2002-09-06 MX MXPA04002418A patent/MXPA04002418A/es active IP Right Grant
- 2002-09-06 AU AU2002339536A patent/AU2002339536B2/en not_active Expired
- 2002-09-06 KR KR1020047003609A patent/KR100940054B1/ko not_active Expired - Fee Related
- 2002-09-06 US US10/489,456 patent/US7169769B2/en not_active Expired - Lifetime
- 2002-09-06 PT PT02777036T patent/PT1427748E/pt unknown
- 2002-09-06 ES ES02777036T patent/ES2305306T3/es not_active Expired - Lifetime
- 2002-09-06 EP EP02777036A patent/EP1427748B1/en not_active Expired - Lifetime
- 2002-09-06 WO PCT/EP2002/010041 patent/WO2003022864A1/en not_active Ceased
- 2002-09-06 HU HU0402139A patent/HUP0402139A3/hu unknown
- 2002-09-06 PL PL368727A patent/PL207493B1/pl not_active IP Right Cessation
- 2002-09-06 BR BR0212409-2A patent/BR0212409A/pt not_active IP Right Cessation
- 2002-09-06 CN CNB02817853XA patent/CN1257913C/zh not_active Expired - Lifetime
- 2002-09-06 AT AT02777036T patent/ATE395352T1/de active
- 2002-09-06 IL IL16045102A patent/IL160451A0/xx unknown
- 2002-09-06 DK DK02777036T patent/DK1427748T3/da active
- 2002-09-06 HR HR20040193A patent/HRP20040193A2/hr not_active Application Discontinuation
- 2002-09-06 NZ NZ531487A patent/NZ531487A/en not_active IP Right Cessation
- 2002-09-06 JP JP2003526937A patent/JP4471653B2/ja not_active Expired - Fee Related
- 2002-09-06 CA CA2505575A patent/CA2505575C/en not_active Expired - Lifetime
- 2002-09-06 DE DE60226623T patent/DE60226623D1/de not_active Expired - Lifetime
- 2002-09-10 AR ARP020103415A patent/AR036462A1/es unknown
-
2004
- 2004-02-18 IL IL160451A patent/IL160451A/en not_active IP Right Cessation
- 2004-02-26 IS IS7165A patent/IS2555B/is unknown
- 2004-03-10 NO NO20041010A patent/NO326624B1/no not_active IP Right Cessation
- 2004-03-10 EC EC2004005012A patent/ECSP045012A/es unknown
- 2004-03-11 ZA ZA200401992A patent/ZA200401992B/en unknown
-
2008
- 2008-06-19 CY CY20081100653T patent/CY1108152T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0317891A (pt) | Tratamento de ferimentos de pele usando polienilfosfatidil colina e alcanolaminas | |
| BR0316203A (pt) | Uso de um agente antialérgico e um esteróide para tratar rinite alérgica | |
| BR0107667A (pt) | Composto de linezolida em forma de cristal que e farmaceuticamente útil como agente antibacteriano e método de preparação do mesmo | |
| BR9916282A (pt) | Composto, uso de um um composto e método de tratamento | |
| ES8401495A1 (es) | Procedimiento para preparar nuevos derivados de 3-ceto- 4,9,19-nor-esteroides. | |
| BR9709427A (pt) | Oxa ácidos e compostos relacionados para tratamento de condições da pele | |
| WO2002022084A3 (en) | Concentrated hair conditioning composition | |
| AR029924A1 (es) | Suspensiones acuosas estabilizadas para administracion parenteral | |
| EP1377245A4 (en) | IMMUNOSTIMULATING COATING FOR SURGICAL DEVICES | |
| BR0001925A (pt) | Utilização de pelo menos um composto, composição cosmética desodorante, utilização de uma composição, utilização do 3,5-di-hidroxiestilbeno, processo para tratar os odores axilares humanos, composto e composição cosmética | |
| NZ331326A (en) | Non-steroidal polycyclic ring sulphamate derivatives, comprising two or more rings wherein at least two of the rings mimic the A and B rings of oestrone, the preparation and their use as oestrone sulphatase inhibitors | |
| BR0312092A (pt) | Uso de derivados de tio-oxindol no tratamento de distúrbios da pele | |
| BR0210920A (pt) | derivados de quinazolina os quais estimulam a liberação de hormÈnio pela paratireóide | |
| HUP0104339A2 (hu) | Eljárás porckárosodások kezelésére | |
| BR0212409A (pt) | Composto esteroidal, uso do mesmo, e, método de tratamento de um animal ou de uma pessoa humana necessitando de estimulação androgênica para um efeito androgênico | |
| BRPI0501718A (pt) | método de tratamento de fibra de cabelo sem etapa de fixação do cabelo e uso do método | |
| BR0207413A (pt) | Composição de condicionamento de tecidos, e, método para o tratamento de tecidos | |
| ES2171943T3 (es) | Nuevo procedimiento de isomerizacion del radical metilo en posicion 10 de derivados de eritromicina. | |
| ID26965A (id) | Obat untuk mencegah dan/atau mengobati kanker payudara, yang mengandung inhibitor aromatase steroid | |
| HUP0301123A3 (en) | Use of exemestane for treatment of hormone-dependent breast cancer | |
| DE3062238D1 (en) | Method for enhancing growth rate and feed efficiency of ruminants | |
| PT92113A (pt) | Processo para a preparacao de novos derivados esteroides 3beta, 17beta-hidroxi--substituidos e de compostos esteroides relacionados | |
| HRP20040634B1 (hr) | POSTUPAK ZA PRIPRAVU 7α-METILSTEROIDA | |
| DK0559706T3 (da) | 2 beta,19-methylenamino-broforbundne steroider som aromataseinhibitorer. | |
| PE20020752A1 (es) | Esteroides con doble enlace delta 14 sustituido en las posiciones 13 y 14 con actividad androgenica y progestagena |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 11A ANUIDADE. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2259 DE 22/04/2014. |